Alex is recognized by Chambers and Legal 500 as an "Up and Coming" and "Rising Star" in securities litigation. He has extensive experience representing public and private companies and their D&Os, as well as investment banks and underwriters, in securities and corporate governance-related litigation and other complex commercial litigation. He also regularly advises companies and their boards on corporate governance best practices and fiduciary and disclosure duties, frequently presents and publishes on these topics, and teaches a full-semester course on transactional and shareholder litigation at the University of California Berkeley School of Law.
Alex earned his Juris Doctor degree,with Honors, Order of the Coif, from the University of Chicago Law School, and graduated with a Bachelor of Arts degree from the University of California, Davis.
Gargi’s work in protein therapeutics includes patent estate development for antibody and fusion protein therapeutics and utilizes her knowledge of the patent landscape in this area to inform strategic portfolio management. In the fields of genomics and proteomics, she has conducted diligence and developed portfolios related to the biochemistry of sequencing technologies, as well as to the associated devices and machine learning methods utilized in sequencing methods. In the field of cancer immunotherapies (immuno-oncology), she has developed portfolios related to cell-based immunotherapy approaches, including targeted immune cell therapies and immunological pathway interventions.
In addition, Gargi assists clients in providing intellectual property support for transactional matters, including diligence for mergers and acquisitions as well as financing rounds. Her technical experience is routinely called upon in helping to develop litigation strategies for complex and high-stakes trials.
Gargi has authored scientific papers in peer-reviewed publications, as well as articles discussing medical and biological research in general-interest newspapers and periodicals. Her doctoral work in Neuroscience from Stanford University focused on structure-function studies in ion channels, with an emphasis on using genetic engineering and electrophysiology to identify structural elements of potassium channels that lead to their voltage and chemical sensitivity.
Palak has served as bond counsel, disclosure counsel, underwriters’ counsel and issuer’s counsel on various types of financing structures including general obligation financings, tax and revenue anticipation financings, current and advance refundings, lease revenue financings, certificates of participation, and special tax financings for Mello Roos community facilities districts, school districts, community college districts, local government and state agency clients. Palak also represents investment banking institutions in governmental and qualified private activity bond transactions across industry segments.
Palak is a dual qualified attorney, licensed to practice law in California and India. Prior to joining Orrick, Palak worked with a law firm in New Delhi, India and represented governmental entities and private parties in international commercial arbitration and business disputes.
His practice focuses on the representation of both public and private companies in connection with employee benefits and compensation-related aspects of corporate transactions, including mergers and acquisitions, spin-offs, and initial public offerings.
Keith also advises on the design, administration and implementation of executive compensation and equity compensation arrangements, including severance arrangements and executive employment agreements.
Prior to joining Orrick, Keith was an attorney-advisor to the Honorable Joseph R. Goeke on the United States Tax Court in Washington, D.C.
Paul's practice includes bond and issuer counsel work for tax-exempt and taxable financings, with a focus on revenue bonds, particularly multifamily housing revenue bonds issued by cities, counties, public authorities and joint powers agencies.
Paul also serves as special counsel for the California Statewide Communities Development Authority for its conduit housing financings.
Mike was Orrick's Securities Litigation practice leader from 2004 to 2012.
He has the unique ability to look at corporate governance problems from a business perspective, to carefully navigate or avoid collateral consequences, and strategically win legal problems. He is frequently recognized for his exemplary work by Chambers, Super Lawyers and The Daily Journal.
Mike focuses on litigation involving the Private Securities Litigation Reform Act of 1995, The Securities Act of 1933, the Securities Act of 1934, the Uniform Standards Act and proceedings initiated by the Securities Exchange Commission, the National Association of Securities Dealers and other self-regulatory organizations.
Mike has extensive experience in litigation involving breaches of fiduciary duty and conducting various types of corporate investigations.
Please do not include any confidential, secret or otherwise sensitive information concerning any potential or actual legal matter in this e-mail message. Unsolicited e-mails do not create an attorney-client relationship and confidential or secret information included in such e-mails cannot be protected from disclosure. Orrick does not have a duty or a legal obligation to keep confidential any information that you provide to us. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.
By clicking "OK" below, you understand and agree that Orrick will have no duty to keep confidential any information you provide.